What microdosing means
“Microdosing” is a popular term for taking a GLP-1 medication at doses lower than the standard approved amounts — sometimes well below even the usual starting dose. It isn’t a formal medical protocol. The word borrowed its shine from other contexts, but here it simply describes using less drug than the label calls for, usually in the hope of gentler side effects or a lower monthly cost.
Standard GLP-1 dosing works differently: you begin at a low introductory dose and follow a planned titration schedule, stepping up every few weeks toward a target. Microdosing departs from that schedule, which is why it’s considered off-label.
Why people consider it — and the catch
The appeal is understandable. GLP-1s can cause nausea and other effects, especially as the dose climbs, and they’re expensive. Using less seems like a way to smooth both problems at once. Compounded products, which can be dialed to custom amounts, made the idea easier to attempt.
The catch is that lower doses generally mean a smaller effect, and the practice hasn’t been studied the way approved regimens have. What counts as a “micro” dose isn’t standardized, self-adjusting invites dosing errors, and what works for one person may do little for another.
What to keep in mind
If you’re curious about lower dosing, the safest path is to raise it with the clinician who prescribes for you rather than improvising. They can tell you whether it fits your goals, help you avoid measuring mistakes, and keep an eye on your response. Our microdosing chart lays out how the numbers are commonly discussed, but it’s a reference — not a recommendation to start. For the bigger picture of how these drugs work, see the GLP-1 overview.